Use of CGRP antagonist compounds for treatment of psoriasis
AssigneeBirkir Sveinsson
InventorBirkir Sveinsson
Life of this patent
Estimating the term…
Abstract
The invention provides methods and compositions for treating, preventing and/or remedying psoriasis, based on compounds that have a calcitonin-related gene peptide (CGRP) antagonistic effect. Methods are also disclosed for identifying compounds with CGRP antagonist activity which thereby are suitable candidate compounds for treating psoriasis.
Claims1
A method of systemic treatment of psoriasis in a subject in need of treatment, the method comprising subcutaneously injecting, to a localized site in the subject in need thereof, a therapeutically effective dose of CGRP 8-37 as the only active agent in a pharmaceutically acceptable formulation, the injection resulting in psoriasis treatment not localized to the site of injection.
Dependencies are inferred from the claim text.